Scholar Rock Holding (SRRK) Interest Coverage Ratio (QoQ) (2017 - 2026)
Scholar Rock Holding (SRRK) Interest Coverage Ratio (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Scholar Rock Holding | 6.30 Bn | 6.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.78% |
| Dec 31, 2025 | -12,617.78% |
| Sep 30, 2025 | 10.24% |
| Jun 30, 2025 | 98.08% |
| Mar 31, 2025 | -54.99% |
| Dec 31, 2024 | -11.07% |
| Sep 30, 2024 | -29.50% |
| Jun 30, 2024 | 50.01% |
| Mar 31, 2024 | -16.29% |
| Dec 31, 2023 | -54.68% |
| Sep 30, 2023 | -44.13% |
| Jun 30, 2023 | -25.80% |
| Mar 31, 2023 | 65.72% |
| Dec 31, 2022 | -78.22% |
| Sep 30, 2022 | 70.65% |
| Jun 30, 2022 | -1,782.84% |
| Mar 31, 2022 | 94.91% |
| Dec 31, 2021 | -8,109.16% |
| Sep 30, 2021 | -13.23% |
| Jun 30, 2021 | -182.12% |